Nichi-Iko Aims For ¥130 Billion In Sales By 2016
This article was originally published in PharmAsia News
Executive Summary
In its four-year mid-term business plan, Nichi-Iko Pharmaceutical Co. Ltd. projects a robust revenue growth powered by a plethora of major product launches.